Hypoxia Triggers TAZ Phosphorylation in Basal A Triple Negative Breast Cancer Cells

• Published in: International journal of molecular sciences 2022-09, Vol.23 (17), p.10119
• Main Authors: Liu, Qiuyu, Stel, Wanda van der, Noord, Vera E. van der, Leegwater, Hanneke, Coban, Bircan, Elbertse, Kim, Pruijs, Joannes T. M., Béquignon, Olivier J. M., Westen, Gerard van, Dévédec, Sylvia E. Le, Danen, Erik H. J.
• Format: Article
• Language: English
• Subjects: Breast cancer; Cell adhesion & migration; Cell cycle; Cytoplasm; Fractionation; Gene expression; Hypoxia; Hypoxia-inducible factor 1; Kinases; Localization; Phosphorylation; Proteins; Src protein; Transcription factors; Tumors; Yes-associated protein
• ISSN: 1422-0067; 1661-6596; 1422-0067
• DOI: 10.3390/ijms231710119

Hypoxia and HIF signaling drive cancer progression and therapy resistance and have been demonstrated in breast cancer. To what extent breast cancer subtypes differ in their response to hypoxia has not been resolved. Here, we show that hypoxia similarly triggers HIF1 stabilization in luminal and basal A triple negative breast cancer cells and we use high throughput targeted RNA sequencing to analyze its effects on gene expression in these subtypes. We focus on regulation of YAP/TAZ/TEAD targets and find overlapping as well as distinct target genes being modulated in luminal and basal A cells under hypoxia. We reveal a HIF1 mediated, basal A specific response to hypoxia by which TAZ, but not YAP, is phosphorylated at Ser89. While total YAP/TAZ localization is not affected by hypoxia, hypoxia drives a shift of [p-TAZ(Ser89)/p-YAP(Ser127)] from the nucleus to the cytoplasm in basal A but not luminal breast cancer cells. Cell fractionation and YAP knock-out experiments confirm cytoplasmic sequestration of TAZ(Ser89) in hypoxic basal A cells. Pharmacological and genetic interference experiments identify c-Src and CDK3 as kinases involved in such phosphorylation of TAZ at Ser89 in hypoxic basal A cells. Hypoxia attenuates growth of basal A cells and the effect of verteporfin, a disruptor of YAP/TAZ-TEAD–mediated transcription, is diminished under those conditions, while expression of a TAZ-S89A mutant does not confer basal A cells with a growth advantage under hypoxic conditions, indicating that other hypoxia regulated pathways suppressing cell growth are dominant.